Cell signaling pathways and HIV-1 therapeutics

Research output: Contribution to journalReview article

Abstract

Host-virus interactions permeate every aspect of both virus life cycle and host response and involve host cell macromolecular machinery and viral elements. It is these intimate interactions that mandate the outcomes of the infection and pathogenesis. It is also these intimate interactions that lay the foundation for the development of pharmaceutical interventions. HIV-1 is no exception in these regards. In the first two decades, HIV/AIDS research has led to the successful development of a number of antiviral inhibitors and the landmark formulation of the suppressive therapy. It has become apparent that this therapy does not offer a complete solution to cure and eradicate the virus. Meanwhile, this therapy has changed the overall landscape of HIV-associated neurological disorders to a more common and prevalent form so-called minor cognitive motor disorder. Thus, there is an important and continued need for new anti-HIV therapeutics. We believe that this is an excellent opportunity to compile and present the latest works being done during the last few years in this exciting field of HIV-host interactions, particularly cell signaling pathways. We hope that this special issue composed of one brief report, eight thematic reviews, and two original articles will serve to foster the exchange of new scientific ideas on HIV-host interactions and anti-HIV therapy and eventually contribute to HIV/AIDS eradication.

Original languageEnglish
Pages (from-to)173-176
Number of pages4
JournalJournal of Neuroimmune Pharmacology
Volume6
Issue number2
DOIs
Publication statusPublished - 1 Jun 2011

    Fingerprint

Keywords

  • Anti-HIV therapeutics
  • Cell signaling
  • Gene expression
  • HIV-1
  • HIV-host interaction
  • Replication

Cite this